Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

European CHMP formally adopts positive opinion for IDM Pharma's Mepact in osteosarcoma

Dec. 30, 2008

FDA approves Novartis' Gleevec for recurrence following surgical removal of a GIST

Dec. 30, 2008

Drais and Diatos sign global license agreement for cancer drug DTS-108

Dec. 30, 2008

Preclinical profile of CAL-101 in hematological cancers disclosed

Dec. 30, 2008

FDA grants marketing authorization to Antisoma's oral fludarabine phosphate in CLL

Dec. 29, 2008

ArQule presents update on development of ARQ-621 and ARQ-761

Dec. 29, 2008

CHMP recommends orphan drug status for Immunomedics' radiolabeled hPAM4

Dec. 29, 2008

SuperGen reports preclinical data for its panel of novel drugs for cancer

Dec. 29, 2008

ArQule signs definitive license agreement with Daiichi Sankyo for selective c-Met inhibitor ARQ-197

Dec. 29, 2008

FDA grants orphan drug designation to TransMolecular's 131I-TM-601 for melanoma

Dec. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...